Novartis Oncology is committed to helping patients living with cancer receive the medicines they need. Patient Assistance NOW Oncology offers quick and easy access to information about the many reimbursement and support programs available. You can get information about our support programs in two ways:
1. Use the Novartis Oncology Program Finder tool, designed to help determine if patients are eligible for a program that can help them gain access to the Novartis Oncology medicines prescribed by their healthcare professional.
2. Call 1-800-282-7630 to speak to one of our knowledgeable staff dedicated to making access to our programs as simple and convenient as possible. We will guide you through the process and direct you to the best program.
Patients with insurance can find information about our support programs immediately below.
Uninsured patients, please click here to find information about our patient assistance programs for the uninsured.
Support for Your Patients with Insurance
Help with Patient Insurance Coverage
Novartis Oncology is dedicated to answering questions about
patients' insurance coverage and providing assistance with the
reimbursement process for Novartis products.
Patient Assistance NOW Oncology offers the following support:
- Insurance verification
Including verification of patients' medical benefits, evaluation of insurance coverage and clarification of co-pay obligations
- Assistance with denials/appeals
Provides assistance to you to work with insurance companies on denied claims or appeals
- Medicare education
Assistance with questions about Medicare Part D and the types of prescription drug coverage it provides
- Alternative funding searches
Assistance searching for, and referrals to other sources of coverage/funding that could help alleviate or reduce costs for patients
- Referrals to Novartis support programs
Novartis Oncology has many product-specific programs to help patients understand their medications and to assist them with their out-of-pocket costs
Disclaimer:
Reimbursement services support and Novartis Pharmaceuticals Corporation do not guarantee success in obtaining reimbursement, nor do we submit appeals on behalf of providers or patients. Third-party payment for medical products and services is affected by numerous factors, not all of which can be anticipated or resolved by Reimbursement services staff.
Support for Novartis Oncology Medications
Many Novartis Oncology products have financial support programs of their own. The product-specific programs offer a wide range of solutions and support and may include:
- Educational programs regarding the diseases they treat
- Trial vouchers offering up to one month of free product for eligible patients
- Therapy-specific support programs that help provide assistance for out–of–pocket costs to pay for medication
Click here for more information about the product-specific programs available and their eligibility requirements.
Co-Pay Assistance through Independent Charitable Foundations
Financial assistance may be available from Independent Charitable Foundations for qualified patients who are unable to afford their co-pay costs. Below is a list of foundations that may be able to provide financial support.
|
|
*The organizations and websites listed above are independently operated and not managed by Novartis Pharmaceuticals Corporation. Novartis assumes no responsibility for any information they may provide.
Support for Uninsured Patients
Novartis Oncology Patient Assistance Program (PAP)
Novartis Oncology PAP provides assistance to eligible US residents experiencing financial hardship who do not have prescription drug coverage. Click here to download the PAP application form.
Patient eligibility requirements:
- US residency
- Meets financial eligibility requirements 1
- No prescription drug coverage (public or private) 2
Financial eligibility program requirements are 300% and 500% above the federal poverty level, depending on the product you need 3
Patients who need more information on the Novartis Oncology PAP program should call the following number, dedicated to PAP patient support: 1-866-884-5906.
1 Exception processes exist for patients who cannot afford their Medicare Part D or B cost share
2 Diagnosis must be consistent with Novartis guidelines
3 Criteria based on 2009 Federal Poverty Guidelines and subject to change
4 Based on adjusted growth income
Disclaimer:
PAP services support and Novartis Pharmaceuticals Corporation do not guarantee success in obtaining reimbursement, nor do we submit appeals on behalf of providers or patients. Third-party payment for medical products and services is affected by numerous factors, not all of which can be anticipated or resolved by PAP services staff.
Support for Novartis Oncology Medications
Many Novartis Oncology products have financial support programs of their own. The product-specific programs offer a wide range of solutions and support and may include:
- Educational programs regarding the diseases they treat
- Trial vouchers offering up to a month of free product for eligible patients
- Therapy–specific support programs that help provide assistance for out–of–pocket costs to pay for medication
Click here for more information about the product–specific programs available and their eligibility requirements.
Additional Information and Support
Partnership for Prescription Assistance (PPA)*
The mission of PPA is to increase awareness of patient assistance programs and boost enrollment of those who are eligible. To access the Partnership for Prescription Assistance by phone, you can call toll-free, 1-888-4PPA-NOW (1-888-477-2669) or view online at www.pparx.org
*PPA is an independent organization not affiliated with Novartis.
Medicare Part D Prescription Drug Benefit
For more information please go to www.medicare.gov or call 1-800-MEDICARE (1-800-633-4227).
Click here for more information on PPA and Medicare Part D Prescription Drug Benefit.
Product Information
To find more information about the Novartis Oncology products you take, click here.
![[Image: Novartis]s](/images/FPO.img.logo.novartis.gif){kind=logo}
Use of website is governed by the Terms of Use and Privacy Statement .
Copyright ©2008 Novartis Pharmaceuticals Corporation. All rights reserved.